BWI: Non Invasive Technology for Checking Cancer Treatment Gains Ground

Press release from Business Wire India
Source: AceProbe
Tuesday, November 27, 2012 06:01 PM IST (12:31 PM GMT)
Editors: General: People; Business: Business services, Healthcare, biotechnology & pharmaceutical; Technology; Healthcare
--------------------------------------------------
Non Invasive Technology for Checking Cancer Treatment Gains Ground
AceProbe Technologies (India), committed to provide cutting edge solutions

Hyderabad, Andhra Pradesh, India, Tuesday, November 27, 2012 -- (Business Wire India) -- Leading scientist and doctors shared latest advancement in technology that allows monitoring cancer without biopsy at the Centre for cellular and molecular biology, Hyderabad, (CCMB) a constituent national laboratory of CSIR, today concluded the international symposia commemorating its silver jubilee year.

Monitoring the Cancer, which is emerging as the largest killer across the globe and has also overtaken the heart disease in countries, has always been a challenge.

Analysis of your urine or a biopsy of a suspicious area, to help guide the therapy decisions is the most common current resort. With the exception of blood cancers, the methods generally can't absolutely tell whether you have cancer or some other noncancerous condition, but they can give your doctor clues about what's going on inside your body.

Early detection and sensitive techniques that could help detect the deadly disease remain to be the game changers in the healthcare for cancers across the globe.

The three day symposia was attended by the eminent speakers from world over to include Dr. Charles Cantor, Chief Scientific Officer, Sequenom Inc., USA who remembers coming to India twenty five years ago at the time of inauguration. Late Shri, Rajiv Gandhi, the then prime minister of India dedicated CCMB to the nation.

Dr. Charles R Cantor, an invited speaker at the meeting concluded his talk and shared the latest advancements in technology and techniques offering a potential to be able to help develop and validate DNA markers that could offer the most sensitive detection of the cancers in the Human body in a non-invasive manner.

Biopsy procedures that incorporates removal of a piece of tissue or a sample of cells from your body so that it can be analyzed in a laboratory, continues to pose challenges along side concerns associated with it such as risk of infection, allergy or even unexpected bleeding.

Dr. Cantor also shared the significant progress the Sequenom company had made alongside the recent recommendations and opinion, The American College of Obstetricians and Gynecologists with regards to non-invasive prenatal testing using cell-free fetal DNA that can be offered to patients at increased risk of aneuploidy - a decision that is favorable to firms such as Sequenom.

In India AceProbe Technologies (India), headed by Dr. Puneet Chandna, a channel partner for Sequenom has been committed to provide cutting edge solutions for an informed heath care through its technology and initiatives is gearing to take up this new challenge and is prioritizing to collaborate with leading research centers in India to help decipher this most recent advances to enable better healthcare and diagnostics.

Worldwide, the technology has widely been validated as an important tool for investigations in a clinical setting across pathways of cancer, cardiovascular diseases, pre-natal disorders and is extremely useful in infectious disease applications of identification and detection of viruses and bacteria. Centers such as Dana Faber, Roswell Park, Memorial Sloan Kettering Cancer Centre, Mayo Clinic etc. are some of the first to embrace the technology.

Going forward, are in the process of validation & completion - a wide range of the assays for Cardiology, Oncology, Infectious diseases, Nutrition and others Genetics Disorders to be unveiled, to suit India's large population size, complex demographic history, and unique social structure.

About Sequenom

Sequenom, Inc. (NASDAQ: SQNM) is a life sciences company committed to improving healthcare through revolutionary genetic analysis solutions. Sequenom develops innovative technology, products and diagnostic tests that target and serve discovery and clinical research, and molecular diagnostics markets. The company was founded in 1994 and is headquartered in San Diego, California.

About AceProbe

AceProbe a life sciences company has been diligently working towards its mission to develop genetic solutions that are evolving as paradigms for futuristic medicine in their role for comprehensive disease detection and informed treatment, ushering in a new era of predictive, preventative and affordable health care. AceProbe solutions include customized, validated assays and panels to support Cardiology, Oncology, Infectious Diseases & Nutrition amongst others that are in its expansion portfolio.



CONTACT DETAILS
Manoj Sharma, +91 9811135420

KEYWORDS
PEOPLE, BUSINESS SERVICES, HEALTHCARE, TECHNOLOGY, HEALTHCARE

If you wish to change your Business Wire India selection please click on this link http://www.businesswireindia.com/media/news.asp and use your personal username and password to login.

Submit your press release at http://www.businesswireindia.com